Can a Postbiotic Help with Obesity or Metabolism problems? Exploring the Power and reality of Akkermansia muciniphila Extracellular Vesicles.
New research shows that microscopic vesicles from a gut-friendly bacterium may offer big benefits for metabolic health.
Key Takeaways
Extracellular vesicles (EVs) derived from Akkermansia muciniphila show stronger anti-obesity effects than the live bacteria itself. Supplement companies offer live bacteria; not EV’s
These EVs reduced body weight, inflammation, and gut permeability in high-fat diet-induced obese mice.
This research introduces EVs as a novel postbiotic therapy—offering targeted microbiome benefits without the need for live probiotics.
While promising, these findings are not yet available in commercial supplements, and human studies are needed.
The Study
Citation:
Ashrafian F, Shahriary A, Behrouzi A, et al. Akkermansia muciniphila-Derived Extracellular Vesicles as a Mucosal Delivery Vector for Amelioration of Obesity in Mice. Front Microbiol. 2019;10:2155. doi:10.3389/fmicb.2019.02155
What Was the Purpose?
Researchers wanted to find out whether Akkermansia muciniphila-derived extracellular vesicles (tiny, bioactive packages secreted by bacteria) could be used to combat obesity and inflammation more effectively than the live probiotic itself.
What Did They Do?
They used obese mice fed a high-fat diet and treated them with either:
Live A. muciniphila
EVs from A. muciniphila
Or a placebo
They monitored body weight, inflammation, gut permeability, and gene expression.
They also did cell line experiments and meta-analysis of nine datasets related to obesity-related genes.
What Did They Find?
EVs reduced body weight more effectively than the live bacteria.
They tightened the gut barrier by increasing tight junction proteins (ZO-1, OCLDN, CLDN-1) and reducing “leaky” markers (CLDN-2).
Inflammatory genes (TNF-α, IL-6, TLR-4) went down, while anti-inflammatory markers (IL-10, TLR-2) went up.
Genes involved in fatty acid oxidation and metabolism (PPAR-α and PPAR-γ) were upregulated.
Interestingly, only live bacteria significantly increased ANGPTL4, a gene tied to fat metabolism.
Why It Matters.
This study supports a growing shift toward “postbiotic” therapies—using bacterial products instead of live organisms. EVs are:
Tiny
Stable
Bioactive
And potentially safer than probiotics for certain populations
They appear to influence both the gut and metabolic pathways in ways that are relevant to many chronic diseases—including obesity, diabetes, and inflammatory bowel conditions.
Limitations & What’s Next
This was an animal study—human clinical trials are needed.
EVs are not yet available in supplement form—though some companies are offer live A. muciniphila.
Mechanistic questions remain—why do EVs outperform live bacteria in some areas but not others? As it seemed that live bacteria did help ANGPTL4; a gene tied to fat metabolism.
Take home message.
In my practice, I’m always searching for therapies that enhance barrier function, microbiome-immune communication, and metabolic signaling. This research highlights the potential of A. muciniphila—and possibly its EVs— for addressing inflammation and obesity-related dysregulation.
Akkermansia muciniphila is worth considering for anyone working on their metabolism. The primary risk of taking it is its financial impact (I joke, but it is expensive!).
There appear to be two major players in this supplement market: the Sacco System, through The Akkermansia Company, offers a pasteurized form of Akkermansia, while Pendulum concentrates on providing live Akkermansia strains through their probiotics. The advantages of pasteurized Akkermansia versus live strains need further exploration.
📬 Thanks for reading Sound Bites with Dr. Adam Rinde. If you found this helpful, feel free to share or comment below. Have you tried Akkermansia-based supplements in your health journey? I'd love to hear about your experience.
Related post
Postbiotics; the real end-game of probiotics and prebiotics.
Conditions of Autoimmunity (like Rheumatoid Arthritis and Inflammatory bowel Disease), Skin Conditions (Like Psoriasis, Eczema, and Acne), and chronic inflammatory conditions all have one thing in common. These conditions leave us looking toward the digestive system and t